Background: High intake of marine n-3 polyunsaturated fatty acids (PUFA) has been
associated with reduced risk of cardiovascular events; however, this has not been confirmed …

Despite the enormous progress in the treatment of atrial fibrillation, mainly with the use of
invasive techniques, many questions remain unanswered regarding the pathomechanism of …

Abstract Background and Aims The benefit of oral anticoagulant (OAC) therapy in atrial
fibrillation (AF) and intermediate stroke risk is debated. In a nationwide Norwegian cohort …

Atrial fibrillation (AF) is a major cause of ischemic stroke and the number of AF patients is
increasing. Thus, up-to-date multifaceted data about the characteristics of AF patients, their …

Objective Atrial fibrillation (AF) is a worldwide healthcare challenge owing to population
ageing. In this study, we assessed the current trends in the incidence and prevalence of AF …

Aims Atrial fibrillation (AF) is the most common arrhythmia worldwide. The AF is associated
with severe mortality, morbidity, and healthcare costs, and guidelines recommend screening …

Atrial fibrillation (AF) is associated with various major adverse cardiac events such as
ischemic stroke, heart failure, and increased overall mortality. However, its association with …

Aims Endurance sport practice is associated with a high prevalence of atrial fibrillation (AF),
which increases the risk of stroke in the general population. However, stroke risk in …

Aims To explore sex-specific time trends in atrial fibrillation (AF) incidence and to estimate
the impact of changes in risk factor levels using individual participant-level data from the …

Importance The temporal trend in adverse events regarding stroke prevention for
nonvalvular atrial fibrillation (NVAF) in the direct oral anticoagulant (DOAC) era was rarely …